Glenzocimab Efficacy and Safety Added to Intravenous Thrombolysis With or Without Mechanical Thrombectomy in Patients With Acute Ischemic Stroke-ACTISAVE: A Prospective, Randomized, Double-Blind Study.

Stroke · 2026 · PMC13117549 · PMID 42044230

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

Analyses of the preplanned primary and secondary end points in subgroups revealed a possible trend toward more unfavorable outcomes in glenzocimab versus placebo in patients who underwent mechanical thrombectomy in addition to thrombolysis.

also in 939 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.